Home
/
INTEGRA LIFESCIENCES HOLDINGS CORP
/
Financials
/
Quarterly
INTEGRA LIFESCIENCES HOLDINGS CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that INTEGRA LIFESCIENCES HOLDINGS CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$357.08M
Apr 26, 2018
Q3
2017
Sep 30, 2017
$278.83M
Oct 26, 2017
Q2
2017
Jun 30, 2017
$282.16M
Jul 26, 2017
Q1
2018
Mar 31, 2017
$258.64M
Apr 26, 2018
Q3
2017
Sep 30, 2016
$250.33M
Oct 26, 2017
Q2
2017
Jun 30, 2016
$249.31M
Jul 26, 2017
Q1
2017
Mar 31, 2016
$236.77M
Apr 26, 2017
Q3
2016
Sep 30, 2015
$226.37M
Oct 28, 2016
Q2
2016
Jun 30, 2015
$212.67M
Jul 28, 2016
Q1
2016
Mar 31, 2015
$202.53M
Apr 27, 2016
Q3
2015
Sep 30, 2014
$197.52M
Nov 4, 2015
Q2
2015
Jun 30, 2014
$231.35M
Jul 31, 2015
Q1
2015
Mar 31, 2014
$215.06M
May 1, 2015
Q3
2014
Sep 30, 2013
$213.25M
Nov 7, 2014
Q2
2014
Jun 30, 2013
$205.55M
Aug 5, 2014
Q1
2014
Mar 31, 2013
$196.65M
May 1, 2014
Q3
2013
Sep 30, 2012
$210.08M
Oct 30, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$402.06M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$415.61M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$382.65M
May 5, 2025
Q3
2025
Sep 30, 2024
$380.83M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$418.18M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$368.87M
May 5, 2025
Q3
2024
Sep 30, 2023
$382.42M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$381.27M
Jul 29, 2024
Q1
2024
Mar 31, 2023
$380.85M
May 6, 2024
Q3
2023
Sep 30, 2022
$385.19M
Oct 25, 2023
Q2
2023
Jun 30, 2022
$397.82M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$376.64M
Apr 26, 2023
Q3
2022
Sep 30, 2021
$386.86M
Oct 26, 2022
Q2
2022
Jun 30, 2021
$389.99M
Jul 27, 2022
Q1
2022
Mar 31, 2021
$360.07M
Apr 27, 2022
Q3
2021
Sep 30, 2020
$370.23M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$258.67M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$354.32M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$379.10M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$383.65M
Aug 10, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.40M)
Oct 30, 2025
Q3
2025
Jun 30, 2025
($484.07M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($484.07M)
Jul 31, 2025
Q2
2025
Mar 31, 2025
($25.29M)
Jul 31, 2025
Q3
2025
Mar 31, 2025
($25.29M)
Oct 30, 2025
Q1
2025
Mar 31, 2025
($25.29M)
May 5, 2025
Q3
2025
Sep 30, 2024
($10.70M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($12.40M)
Jul 31, 2025
Q3
2025
Jun 30, 2024
($12.40M)
Oct 30, 2025
Q1
2025
Mar 31, 2024
($3.28M)
May 5, 2025
Q2
2025
Mar 31, 2024
($3.28M)
Jul 31, 2025
Q3
2025
Mar 31, 2024
($3.28M)
Oct 30, 2025
Q3
2024
Sep 30, 2023
$19.50M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$4.18M
Jul 29, 2024
Q3
2024
Jun 30, 2023
$4.18M
Nov 4, 2024
Q3
2024
Mar 31, 2023
$24.23M
Nov 4, 2024
Q1
2024
Mar 31, 2023
$24.23M
May 6, 2024
Q2
2024
Mar 31, 2023
$24.23M
Jul 29, 2024
Q3
2023
Sep 30, 2022
$49.92M
Oct 25, 2023
Q3
2023
Jun 30, 2022
$44.79M
Oct 25, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$11.76M
Oct 30, 2025
Q2
2025
Jun 30, 2025
($512.67M)
Jul 31, 2025
Q1
2025
Mar 31, 2025
($15.50M)
May 5, 2025
Q3
2025
Sep 30, 2024
($8.15M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($3.03M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
$3.96M
May 5, 2025
Q3
2024
Sep 30, 2023
$26.59M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$12.50M
Jul 29, 2024
Q1
2024
Mar 31, 2023
$36.38M
May 6, 2024
Q3
2023
Sep 30, 2022
$65.05M
Oct 25, 2023
Q2
2023
Jun 30, 2022
$59.87M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$46.16M
Apr 26, 2023
Q3
2022
Sep 30, 2021
$56.44M
Oct 26, 2022
Q2
2022
Jun 30, 2021
$51.85M
Jul 27, 2022
Q1
2022
Mar 31, 2021
$30.71M
Apr 27, 2022
Q3
2021
Sep 30, 2020
$57.54M
Nov 2, 2021
Q2
2021
Jun 30, 2020
$14.08M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$27.10M
Apr 29, 2021
Q3
2020
Sep 30, 2019
($20.59M)
Oct 29, 2020
Q2
2020
Jun 30, 2019
$45.96M
Aug 10, 2020